C. J. Melief

发表

Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells

W. Kast, C. Melief, H. Geuze, 1995, The Journal of experimental medicine.

Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody‐induced nonspecific cytotoxicity of class I‐ and class II‐allospecific cytotoxic T cell clones

H. Spits, G. V. van Seventer, K. C. Kuijpers, 1988, European journal of immunology.

Immunological characterization of non‐Hodgkin's lymphoma: Enrichment of neoplastic cells from lymphoid tissues and blood

F. Cleton, A. von dem Borne, P. van Heerde, 1982, Cancer.

T Cell-Dependent Immunoglobulin Synthesis in the Human System. Studies with T Cell-Specific Monoclonal Antibodies

F. Miedema, F. Terpstra, C. M. Melief, 1986 .

Induction of immunoglobulin synthesis by interleukin 2 is T4+/T8− cell dependent. A role for interleukin 2 in the pokeweed mitogen‐driven system

F. Miedema, R. Sauerwein, L. Aarden, 1985, European journal of immunology.

Abolition of specific immune response defect by immunization with dendritic cells

W. Kast, C. Melief, C. Boog, 1985, Nature.

Processing of exogenous protein antigen by murine dendritic cells for presentation to cytotoxic T lymphocytes.

C. Melief, D. Schuurhuis, M. De Bruijn, 1997, Advances in experimental medicine and biology.

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.

M. Feltkamp, W. Kast, C. Melief, 1994, Molecular immunology.

Pretransplantation blood transfusion revisited.

W. Kast, C. Melief, I. T. Ten Berge, 1991, The New England journal of medicine.

Both Fc receptors and lymphocyte‐function‐associated antigen 1 on human Tγ lymphocytes are required for antibody‐dependent cellular cytotoxicity (killer cell activity)

F. Miedema, H. Spits, P. Tetteroo, 1984, European journal of immunology.

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes.

C. Melief, C. J. Melief, 1992, Advances in cancer research.

Alternative molecular form of human T cell‐specific antigen CD27 expressed upon T cell activation

R. V. van Lier, E. D. Vries, J. Borst, 1989, European journal of immunology.

Protection from lethal graft‐vs.‐host disease by donor stem cell repopulation

L. Rozendaal, S. Pals, E. Gleichmann, 1992, European journal of immunology.

Induction and characterization of cytotoxic T‐lymphocytes recognizing a mutated p21ras peptide presented by HLA‐A*0201

W. Kast, P. Schrier, A. van Elsas, 1995, International journal of cancer.

Fine peptide specificity of cytotoxic T lymphocytes directed against adenovirus‐induced tumours and peptide‐mhc binding

W. Kast, C. M. Melief, C. J. Melief, 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Enhanced Recognition in H-2 Db Mutant bml3 Mice

M. Ressing, W. Kast, C. Boog, 2022 .

Cd8 T‐cell recognition of human 5T4 oncofetal antigen

P. Stern, T. Taher, P. V. van Veelen, 2006, International journal of cancer.

Immunobiology of the expanded T cells in T-cell leukemia and T-gamma lymphocytosis.

F. Miedema, C. Melief, C. J. Melief, 1986, Leukemia research.

Regulatory activity of neoplastic T cells in Sezary syndrome on in vitro immunoglobulin production.

C. Meijer, F. Miedema, R. Willemze, 1984, Leukemia research.

Surface markers and functional properties of non‐Hodgkin's lymphoma cells in relation to histology

T. Splinter, P. van Heerde, C. M. Melief, 1978, Cancer.

Chronic lymphocytic leukemia immunologic markers and functional properties of the leukemic cells

R. van der Gaag, M. V. van't Veer, H. Rümke, 1982, Cancer.

Processing and presentation of intact hen egg‐white lysozyme by dendritic cells

C. Harding, J. Nieland, M. De Bruijn, 1992, European journal of immunology.

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells

W. Kast, C. Melief, L. D. de Waal, 1984, The Journal of experimental medicine.

Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses

C. Melief, C. Boog, C. M. Melief, 1988, European journal of immunology.

Specific immune responses restored by alteration in carbohydrate chains of surface molecules on antigen‐presenting cells

C. Melief, H. Ploegh, J. Neefjes, 1989, European journal of immunology.

Cytotoxic T lymphocytes against the antigen‐processing‐defective RMA‐S tumor cell line

W. Kast, A. Sijts, J. Nieland, 1992, European journal of immunology.

Allosuppression of B cells in vitro by graft‐vs.‐host reaction‐derived T cells is caused by cytotoxic T lymphocytes

M. Schilham, S. Pals, E. Gleichmann, 1989, European journal of immunology.

Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen

S. H. van der Burg, P. Schrier, A. van Elsas, 1996, European journal of immunology.

Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes.

J. Drijfhout, W. Kast, P. Kenemans, 1997, Cancer letters.

Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor.

M. Feltkamp, W. Kast, C. Melief, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

PRODUCTIVE HTLV-III INFECTION OF HUMAN B CELL LINES

J. Goudsmit, F. Miedema, M. Tersmette, 1985, The Lancet.

Anti‐HLA‐class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell level

F. Miedema, M. D. de Rie, R. W. V. van Lier, 1987, European journal of immunology.

Peptide selection by MHC class I molecules

Hidde L. Ploegh, T. Schumacher, W. Kast, 1991, Nature.

Intra‐H‐2 and T cell requirements for the induction of maximal positive and negative allogeneic effects in vitro

E. Gleichmann, C. M. Melief, A. Rolink, 1983, European journal of immunology.

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

W. Kast, C. Melief, R. Meloen, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus‐like graft‐versus‐host disease

S. Pals, E. Gleichmann, C. M. Melief, 1990, Clinical and experimental immunology.

Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay.

J. Drijfhout, R. Brandt, W. Kast, 1995, Human immunology.

Successful immunotherapy of an intraocular tumor in mice.

W. Kast, C. Melief, A. Boer, 1999, Cancer research.

Antigen Presentation to Cytotoxic T Cells Vectors Enhances Transgene-Encoded Subgroup B Fiber-Modified Adenovirus Monocyte-Derived Dendritic Cells with Highly Efficient Transduction of Human

M. Havenga, A. Lemckert, A. Bout, 2001 .

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles.

D. Lowy, W. Kast, C. Melief, 1998, Virology.

The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER.

C. Melief, P. Barker, E. Joly, 1996, Immunity.